esc semaglutide 2025: evidence of efficacy in Swiss T2D patients retatrutide clinical trials safety ESC

Did you know Rytary can cause drowsiness in some people with Parkinsons disease

New in FY2027 GLP-1 Medication Coverage for the Treatment of Obesity Coverage for GLP-1 medications prescribed for the treatment of obesity only, under GIC health plans, will end at the end of...

The pharmaceutical industry, and especially the part of the industry that Novo Nordisk is in, is currently changing to become more consumer-oriented, the new chairman of the board says.

In that same spirit, were glad to pass this benefit on to patients here in Pakistan

We are thrilled to welcome back two returning guests, Dr

If you are undergoing a particular FBC investigation and need these specific markers for your GP, we advise you to come to one of our clinics for a venous sample